241 related articles for article (PubMed ID: 31796941)
1. Has the time come for de-escalation in the management of oropharyngeal carcinoma?
Durkova J; Boldis M; Kovacova S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Dec; 163(4):293-301. PubMed ID: 31796941
[TBL] [Abstract][Full Text] [Related]
2. Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
Nichols AC; Lang P; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Fung K; de Almeida JR; Bayley A; Goldstein DP; Eskander A; Husain Z; Bahig H; Christopoulous A; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Mendez A; Winquist E; Read N; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Corsten M; Rajaraman M; Johnson-Obaseki S; Eapen L; Odell M; Chandarana S; Banerjee R; Dort J; Matthews TW; Hart R; Kerr P; Dowthwaite S; Gupta M; Zhang H; Wright J; Parker C; Wehrli B; Kwan K; Theurer J; Palma DA
BMC Cancer; 2020 Feb; 20(1):125. PubMed ID: 32059705
[TBL] [Abstract][Full Text] [Related]
3. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
4. De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research.
Petar S; Marko S; Ivica L
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4599-4603. PubMed ID: 33599841
[TBL] [Abstract][Full Text] [Related]
5. Treatment de-intensification strategies for head and neck cancer.
Kelly JR; Husain ZA; Burtness B
Eur J Cancer; 2016 Nov; 68():125-133. PubMed ID: 27755996
[TBL] [Abstract][Full Text] [Related]
6. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
[TBL] [Abstract][Full Text] [Related]
7. [Treatment de-intensification strategies for HPV-driven oropharyngeal cancer: A short review].
Lahmamssi C; Guy JB; Benchekroun N; Bouchbika Z; Taoufik N; Jouhadi H; Sahraoui S; Benider A; Ben Mrad M; Jmour O; Bousarsar A; Lan ML; Lei Q; Benna M; Moslemi D; Vallard A; Magné N
Cancer Radiother; 2020 Jun; 24(3):258-266. PubMed ID: 32229067
[TBL] [Abstract][Full Text] [Related]
8. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
9. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Masterson L; Moualed D; Masood A; Dwivedi RC; Benson R; Sterling JC; Rhodes KM; Sudhoff H; Jani P; Goon P
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010271. PubMed ID: 24532092
[TBL] [Abstract][Full Text] [Related]
10. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
11. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.
Masterson L; Moualed D; Liu ZW; Howard JE; Dwivedi RC; Tysome JR; Benson R; Sterling JC; Sudhoff H; Jani P; Goon PK
Eur J Cancer; 2014 Oct; 50(15):2636-48. PubMed ID: 25091798
[TBL] [Abstract][Full Text] [Related]
12. Special Issue about Head and Neck Cancers: HPV Positive Cancers.
Economopoulou P; Kotsantis I; Psyrri A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403287
[TBL] [Abstract][Full Text] [Related]
13. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
Maxwell JH; Grandis JR; Ferris RL
Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
[TBL] [Abstract][Full Text] [Related]
14. Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?
Samuels SE; Eisbruch A; Beitler JJ; Corry J; Bradford CR; Saba NF; van den Brekel MW; Smee R; Strojan P; Suárez C; Mendenhall WM; Takes RP; Rodrigo JP; Haigentz M; Rapidis AD; Rinaldo A; Ferlito A
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):2877-94. PubMed ID: 26463714
[TBL] [Abstract][Full Text] [Related]
15. Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives.
Mirghani H; Amen F; Blanchard P; Moreau F; Guigay J; Hartl DM; Lacau St Guily J
Int J Cancer; 2015 Apr; 136(7):1494-503. PubMed ID: 24622970
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.
Chau NG; Rabinowits G; Haddad RI
Curr Treat Options Oncol; 2014 Dec; 15(4):595-610. PubMed ID: 25240410
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
18. [De-escalation concepts for chemoradiotherapy of HPV-positive oropharyngeal carcinomas: pros and cons].
Rühle A; Nicolay NH
HNO; 2021 Apr; 69(4):278-284. PubMed ID: 33048200
[TBL] [Abstract][Full Text] [Related]
19. Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How?
Wirth LJ; Burtness B; Nathan CO; Grégoire V; Richmon J
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():364-372. PubMed ID: 31099643
[TBL] [Abstract][Full Text] [Related]
20. HPV positive oropharyngeal cancer and treatment deintensification: how pertinent is it?
Laskar SG; Swain M
J Cancer Res Ther; 2015; 11(1):6-9. PubMed ID: 25879328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
